🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07592195
Recruiting Not applicable

A Study on the Effects of Breathing Exercises and Aerobic Exercise on the Health of Men in Drug Rehabilitation

NCT07592195 · tracked via the Priya Life Science China tracker
Sponsor
Southwest Medical University
Phase
Not applicable
Started
2026-04-01
Last updated
2026-05-18

Condition(s) studied

Disorders, Substance Related

Investigational drug(s) / intervention(s)

Resistance Breathing TrainingAerobic Exercise

Resistance Breathing Training: Warm-up (5 minutes) → Threshold resistance breathing trainer (30 minutes) → Cool-down stretches (5 minutes).During joint training, each session lasts 15 minutes.

Aerobic Exercise: Warm-up (5 minutes) → Main exercise (30 minutes, at 65%-85% of maximum heart rate or a Borg RPE score of 12-14) → Cool-down and stretching (5 minutes).During joint training sessions, each training session lasts 15 minutes.

Study summary

This study aims to investigate the effects of an 8-week combined exercise program on male individuals in drug rehabilitation. The program integrates resistance-based breathing training with aerobic exercise. The investigators seek to determine whether this combined exercise program is more effective than a single form of exercise in improving participants' physical health and quality of life. The primary research questions to be addressed include: Does this combined exercise program produce better results than single-form training (resistance-based breathing training or aerobic exercise performed separately) in improving physiological indicators such as cardiopulmonary function and muscle strength in male individuals in drug rehabilitation? Does this combined exercise program yield greater benefits than single-form training in reducing anxiety and depression and improving quality of life among men in drug rehabilitation? This study will conduct a randomized controlled trial. Researchers will compare three different intervention groups-the combined training group, the resistance-breathing training group, and the aerobic exercise group-to verify the potential advantages of the combined program over single-form exercise. Participants will: Complete an 8-week exercise intervention, consisting of three sessions per week, each lasting approximately 40 minutes, under professional guidance and supervision. Undergo comprehensive assessments before and after the intervention, including cardiopulmonary function tests, body composition analysis, and questionnaires on mental health and quality of life.

Eligibility

Sex
MALE
Min age
18 Years
Max age
50 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Male, aged 18 to 50 years, able to understand and comply with the study protocol * Meets the DSM-5 diagnostic criteria for substance use disorder; in rehabilitation for ≥1 month; withdrawal symptoms are stable (confirmed by medical staff) * No severe cardiovascular/cerebrovascular disease, respiratory disease, musculoskeletal injury, or other contraindications to physical activity * Basic reading and writing ability to independently complete questionnaire assessments * Voluntarily signed informed consent and committed to complying with the 8-week training program Exclusion Criteria: * Presence of contraindications to exercise (e.g., recent fracture, severe arrhythmia, uncontrolled hypertension) * Concurrent severe mental disorders (e.g., schizophrenia, acute depressive episode) or currently receiving unstable psychiatric medication * Currently participating in other intervention studies or clinical trials * Expected training compliance rate \<70% (e.g., unable to complete the 8-week intervention due to transfer or disciplinary action) * Unable to continue participation for personal reasons (e.g., early discharge, serious disciplinary violation)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Yongtingli Luzhou China Recruiting

More Southwest Medical University trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07592195 on ClinicalTrials.gov ↗ ← All trials in China